9 August 2016 - Deborah Wilkes
Archived
Generics giant Mylan has completed the acquisition of Sweden's Meda. President Rajiv Malik said acquiring Meda opened up a number of new opportunities for Mylan, such as "significantly expanding our OTC presence into a US$1 billion business".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.